article

1. Treatment of Persons with Rheumatoid Arthritis with a History of Cancer..  Current rheumatology reports.  27:-. 2025
2. Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases..  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.  2025
3. Patient characteristics and outcomes of emergency visits in psoriatic arthritis: results from the U.S. Nationwide Emergency Department Sample..  Clinical rheumatology.  44:3573-3579. 2025
4. Sonographic Signatures of Immune Checkpoint Inhibitor-Associated Musculoskeletal Adverse Events..  Cancers.  17. 2025
5. Beliefs, preferences, and informational needs of patients with rheumatoid arthritis and concomitant cancer: a qualitative study..  BMC rheumatology.  9:-. 2025
6. Ageism in Rheumatology: The Health Care Professional's Perspective..  Arthritis care & research.  77:1254-1262. 2025
7. Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis..  Rheumatology (Oxford, England).  64:3434-3443. 2025
8. Prevalence of Frailty and Associated Factors in a US-Wide Cohort of Rheumatic Diseases..  ACR open rheumatology.  7:-. 2025
9. Burden of Emergency Department Visits and Their Outcomes Among Patients With Rheumatoid Arthritis: Insights From the Nationwide Emergency Department Sample..  ACR open rheumatology.  7:-. 2025
10. Tumour necrosis factor inhibitor safety in rheumatoid arthritis with early-stage cancer..  The Lancet. Rheumatology.  7:e307-e308. 2025
11. Association Between Rheumatoid Arthritis, Frailty Status, and Mortality in Older Adults with Bladder Cancer..  Clinical genitourinary cancer.  23:-. 2025
12. Social media in advancing equity and collaboration in rheumatology: the CORDIALITY review..  RMD open.  11. 2025
13. Changes in Long-Term Glucocorticoid Use Among Older Adults After New Diagnosis of Late-Onset Rheumatoid Arthritis..  ACR open rheumatology.  7:-. 2025
14. Advancing Rheumatologic Care in Older Adults: Highlights From the 2024 American Geriatrics Society Annual Scientific Meeting..  Arthritis care & research.  77:557-563. 2025
15. Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritis..  BMC rheumatology.  9:-. 2025
16. Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analysis..  Frontiers in immunology.  -. 2024
17. Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban Areas..  Arthritis care & research.  77:23-29. 2024
18. Frailty integration in medical specialties: Current evidence and suggested strategies from the Clin-STAR frailty interest group..  Journal of the American Geriatrics Society.  73:1029-1040. 2024
19. Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk..  JAMA network open.  7:-. 2024
20. Low Socioeconomic Status and Female Sex are Associated With Worse Functional Status in Axial Spondyloarthritis..  Arthritis care & research.  77:376-384. 2024
21. Frailty and its association with readmissions in patients with rheumatoid arthritis: A national readmissions database study..  Clinical rheumatology.  43:3639-3646. 2024
22. Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers With Autoimmune or Inflammatory Rheumatic Disease: A Retrospective Cohort Analysis From the National COVID Cohort Collaborative..  Arthritis care & research.  77:143-155. 2024
23. Inflammation and aging-related disease: A transdisciplinary inflammaging framework..  GeroScience.  47:515-542. 2024
24. The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease..  Arthritis & rheumatology (Hoboken, N.J.).  76:1730-1738. 2024
25. Association Between Frailty Status and Readmissions in Hospitalized Patients With Systemic Lupus Erythematosus..  ACR open rheumatology.  6:700-706. 2024
26. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases..  Arthritis & rheumatology (Hoboken, N.J.).  76:1201-1213. 2024
27. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases..  Arthritis care & research.  76:1070-1082. 2024
28. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases..  Arthritis care & research.  76:1051-1069. 2024
29. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases..  Arthritis & rheumatology (Hoboken, N.J.).  76:1182-1200. 2024
30. Effect of telephone reminders on adherence to anti-rabies vaccine amongst animal bite patients in North India: A randomised, single-blind, parallel-group, single-centre, interventional superiority trial..  IJID regions.  -. 2024
31. Prevalence and Factors Associated with De-escalation of Anti-TNFs in Older Adults with Rheumatoid Arthritis: A Medicare Claims-Based Observational Study..  Drugs & aging.  41:601-613. 2024
32. The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis: A Scoping Review..  Rheumatic diseases clinics of North America.  50:325-335. 2024
33. Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management..  Rheumatic diseases clinics of North America.  50:269-279. 2024
34. Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs..  Arthritis care & research.  76:627-635. 2024
35. Prognosis of Merkel cell carcinoma patients with autoimmune disorders, other types of immune dysfunction, or immunocompetent status: Analysis of 762 patients..  Journal of the American Academy of Dermatology.  90:1018-1020. 2024
36. Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology..  Current opinion in rheumatology.  36:113-119. 2023
37. Initiation of Disease-Modifying Antirheumatic Drugs in Older Medicare Beneficiaries With New Diagnosis of Late-Onset Rheumatoid Arthritis..  ACR open rheumatology.  5:694-700. 2023
38. JAK inhibitors and black box warnings: what is the future for JAK inhibitors?.  Expert review of clinical immunology.  19:1-13. 2023
39. Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis..  Clinical rheumatology.  43:87-94. 2023
40. Immune-related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity..  Immunological reviews.  318:81-88. 2023
41. Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors..  Drug safety.  46:1049-1071. 2023
42. Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events..  Journal for immunotherapy of cancer.  11. 2023
43. Awareness and Hesitancy of COVID-19 and other Vaccines among People Living with HIV/AIDS Attending Antiretroviral Therapy (ART) Center in North India..  Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine.  48:492-496. 2023
44. 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis..  Arthritis & rheumatology (Hoboken, N.J.).  75:1299-1311. 2023
45. 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis..  Arthritis care & research.  75:1603-1615. 2023
46. Use of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision-Making Between Patients With Cancer and Clinicians..  ACR open rheumatology.  5:305-307. 2023
47. Racial/ethnic disparities in the risk of preterm birth among women with systemic lupus erythematosus or rheumatoid arthritis..  Clinical rheumatology.  42:2437-2444. 2023
48. Racial disparities in pregnancy outcomes among women with rheumatic diseases: A systematic literature review..  Seminars in arthritis and rheumatism.  -. 2023
49. Birth Outcomes and Rehospitalizations Among Pregnant Women With Rheumatoid Arthritis and Systemic Lupus Erythematosus and Their Offspring..  Arthritis care & research.  75:2022-2031. 2023
50. Burden, Causes and Outcomes of Hospitalization in Patients with Giant Cell Arteritis: A US National Cohort Study..  Arthritis care & research.  75:1830-1837. 2023
51. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases..  Arthritis & rheumatology (Hoboken, N.J.).  75:333-348. 2023
52. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases..  Arthritis care & research.  75:449-464. 2023
53. Supporting International Medical Graduates in Rheumatology: A Call to Action..  Arthritis & rheumatology (Hoboken, N.J.).  75:145-148. 2022
54. Predictors of Thirty-Day Hospital Readmissions in Systemic Lupus Erythematosus in the US: A Nationwide Study..  Arthritis care & research.  75:989-997. 2022
55. Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)..  Seminars in arthritis and rheumatism.  -. 2022
56. The Impact of Disease Severity Measures on Survival in U.S. Veterans with Rheumatoid Arthritis-Associated Interstitial Lung Disease..  Rheumatology (Oxford, England).  61:4667-4677. 2022
57. Risk of Prostate Cancer in U.S. Veterans with Rheumatoid Arthritis..  Arthritis care & research.  75:785-792. 2022
58. Abnormal echocardiographic findings after COVID-19 infection: a multicenter registry..  The international journal of cardiovascular imaging.  39:1-2. 2022
59. Optimizing Medication Use in Older Adults With Rheumatic Musculoskeletal Diseases: Deprescribing as an Approach When Less May Be More..  ACR open rheumatology.  4:1031-1041. 2022
60. Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease..  Seminars in arthritis and rheumatism.  -. 2022
61. Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey..  RMD open.  8. 2022
62. Determinants of Cervical Cancer Screening Patterns Among Women With Systemic Lupus Erythematosus..  The Journal of rheumatology.  49:1236-1241. 2022
63. The role of a noninvasive index 'Spo2/ Fio2' in predicting mortality among patients with COVID-19 pneumonia..  The American journal of emergency medicine.  -. 2022
64. Physical Function and Fatigue Recovery at 6-Months after Hospitalization for COVID-19..  PM & R : the journal of injury, function, and rehabilitation.  15:314-324. 2022
65. Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. Veterans..  Respiratory medicine.  -. 2022
66. Association of rheumatoid arthritis with mortality in chronic kidney disease: a cohort study..  Clinical rheumatology.  41:2669-2676. 2022
67. Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey..  Rheumatology advances in practice.  6:-. 2022
68. Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases..  The Lancet. Rheumatology.  4:e380-e382. 2022
69. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis..  Arthritis & rheumatology (Hoboken, N.J.).  74:766-775. 2022
70. COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey..  The Lancet. Rheumatology.  4:e237-e240. 2022
71. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US..  JAMA internal medicine.  182:153-162. 2022
72. Non-English Language Preference Associated With Decreased Rheumatology Telehealth Use During the COVID-19 Pandemic..  ACR open rheumatology.  4:385-394. 2022
73. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey..  RMD open.  7. 2021
74. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis..  Arthritis & rheumatology (Hoboken, N.J.).  73:1108-1123. 2021
75. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis..  Arthritis care & research.  73:924-939. 2021
76. Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease..  Annals of translational medicine.  9:-. 2021
77. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry..  Annals of the rheumatic diseases.  80:1137-1146. 2021
78. Impact of rheumatoid arthritis and biologic and targeted synthetic disease modifying antirheumatic agents on cancer risk and recurrence..  Current opinion in rheumatology.  33:292-299. 2021
79. Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors..  Scientific reports.  11:-. 2021
80. Clinical and laboratory features of patients with focal lymphocytic sialadenitis on minor salivary gland biopsy for sicca symptoms: A single-center experience..  Medicine.  100:-. 2021
81. Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans..  Annals of the American Thoracic Society.  18:598-605. 2021
82. Musculoskeletal sarcoidosis: A single center experience over 15 years..  International journal of rheumatic diseases.  24:533-541. 2021
83. Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid Arthritis..  Arthritis & rheumatology (Hoboken, N.J.).  73:392-400. 2021
84. Trends in Hospitalization Rates, Major Causes of Hospitalization, and In-Hospital Mortality in Rheumatoid Arthritis in the United States From 2000 to 2014..  ACR open rheumatology.  2:715-724. 2020
85. Pregnancy after bariatric surgery in women with rheumatic diseases and association with adverse birth outcomes..  Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.  17:406-413. 2020
86. Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients..  EJHaem.  1:537-544. 2020
87. Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review..  Seminars in arthritis and rheumatism.  50:1191-1201. 2020
88. Trends of lymphoma incidence in US veterans with rheumatoid arthritis, 2002-2017..  RMD open.  6. 2020
89. Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality..  Arthritis care & research.  72:950-958. 2020
90. Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis..  RMD open.  6. 2020
91. Immunologic adverse events from immune checkpoint therapy..  Best practice & research. Clinical rheumatology.  34:-. 2020
92. Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis..  Arthritis care & research.  72:561-576. 2020
93. Immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: A single-center experience..  Medicine.  2019
94. Impact of autoimmune rheumatic diseases on birth outcomes: A population-based study.  RMD Open.  2019
95. Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis.  Seminars in Arthritis and Rheumatism.  2019
96. Is Transdermal Multivitamin Patch Effective in Gastric Bypass Patients?.  Obesity Surgery.  2019
97. Malondialdehyde–Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis–Associated Interstitial Lung Disease.  Arthritis and Rheumatology.  2019
98. Rheumatoid arthritis: Therapeutic strategies after inadequate response to initial TNF inhibitor therapy.  Journal of Clinical Outcomes Management.  2019
99. Multicentric Reticulohistiocytosis: A Multicenter Case Series and Review of Literature.  Journal of Clinical Rheumatology.  2018
100. Large-scale deployment of a rice 6 K SNP array for genetics and breeding applications..  Rice (New York, N.Y.).  10:-. 2017
101. Abnormal thymic maturation and lymphoproliferation in MRL-Fas ^lpr/lpr mice can be partially reversed by synthetic oligonucleotides: Implications for systemic lupus erythematosus and autoimmune lymphoproliferative syndrome.  Lupus.  2017
102. Monoarticular Arthritis.  Medical Clinics of North America.  2017
103. Septic Arthritis and Prosthetic Joint Infections in Older Adults.  Infectious Disease Clinics of North America.  2017
104. Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis..  Arthritis & rheumatology (Hoboken, N.J.).  68:2394-402. 2016
105. Alterations in nuclear structure promote lupus autoimmunity in a mouse model.  DMM Disease Models and Mechanisms.  2016
106. Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations.  Journal of Allergy and Clinical Immunology.  2016
107. Cat-scratch fever and lymphadenopathy in a rheumatoid arthritis patient on tocilizumab.  Journal of Clinical Rheumatology.  2015
108. Renal cell carcinoma metastatic to the orbit in a patient with wegener granulomatosis.  Journal of Neuro-Ophthalmology.  2015
109. Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosus.  Arthritis Research and Therapy.  2014
110. Role of robotic-assisted surgery in benign esophageal diseases.  Journal of Robotic Surgery.  2014
111. Lower extremity mass.  Clinical Case Reports.  2013
112. Tuberous sclerosis and fulminant lupus in a young woman.  Journal of Clinical Rheumatology.  2013
113. What is the diagnosis for this rash?.  Clinical Case Reports.  2013
114. The T cell in Sjogren's syndrome: Force majeure, not spectateur.  Journal of Autoimmunity.  2012